Korean J Med.
1998 Sep;55(3):383-392.
Left Ventricular Hypertrophy in End-Stage Renal Disease
- Affiliations
-
- 1Department of Internal medicine, Kyung Hee University School of Medicine, Seoul, Korea.
Abstract
OBJECTIVE
Left ventricular hypertrophy is common and major complication in patients with end stage renal
disease (ESRD), but pathogenesis is not clear. We have used echocardiography to evaluate influential factors and
contractile performance according to the geometry of left ventricle.
METHODS
We measured left ventricular mass, the extent of pericardial effusion and systolic function of left ventricle
with M-mode and two dimensional echocardiography in 99 cases of ESRD from March 1993 to March 1996.
RESULTS
1) Body surface area and systolic blood pressure was higher in men than those in women. But, there was no difference
in LV mass index or systolic function between the sex.
2) Among the 99 patients with ESRD, 89 cases (90%) had increased ventricular mass and 10 cases had normal
ventricular mass. In the left ventricular hypertrophy groups, 60 cases had concentric hypertrophy, 29 cases had eccentric
hypertrophy.
3) In patients with normal ventricular mass, hypertension and pericardial effusion were less frequent than in those
with left ventricular hypertrophy. In patients with concentric hypertrophy, systolic blood pressure and body surface area
were increased and serum albumin was decreased as compared to patients with eccentric hypertrophy. In patients with
eccentric hypertrophy, duration of dialysis was increased. But, the result of Logistic analysis showed that systolic blood
pressure and serum albumin were reliable factors for the geometry of left ventricle.
4) In patients with eccentric hypertrophy, LV mass index was significantly correlated with the concentration of serum
alkaline phosphatase and phosphate. But, in patients with concentric hypertrophy, any factors were not correlated with
LV mass index.
5) Systolic performances such as ejection fraction and fractional shortening were decreased in patients with eccentric
hypertrophy.
6) The pattern of left ventricular hypertrophy was not different among non-dialysis group, hemodialysis group and
CAPD group.
CONCLUSION
In patients with ESRD, left ventricular hypertrophy is a common complication and most common
hypertrophic type is concentric hypertrophy. The geometry of left ventricular hypertrophy may be influenced by various
factors such as systolic blood pressure and serum albumin concentration and influence on the systolic performance of left
ventricle. Further study for the geometry of left ventricle and the prognosis may be necessary for the improvement of
cardiovascular complications in patients with ESRD.